GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Modalis Therapeutics 4883.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

26

+8.33%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Forecasts

Analyst averages for the fiscal years ahead

FY2026
Revenue¥800.0m
Revenue, highest¥800.0m
Revenue, lowest¥800.0m
Earnings per share-22.20
Earnings per share, highest-22.20
Earnings per share, lowest-22.20
Analysts1

Earnings against forecasts

Earnings per share by fiscal quarter

Q4 2023Q3 2023
Forecast0.06-14.50
Reported-24.47-34.70
Difference-40883.3%-139.3%

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

1 / 10

Revenue growth 0.0% a year over 10 years. Return on equity -77.1%.

Model fair value

415.78

From earnings —, from revenue 415.78.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.